{
  "name": "TEST-TPQ",
  "description": "The target promotion questionnaire is used to promote a gene to target",
  "version": null,
  "questions": [
    {
      "identification": "2A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Humans-Contributes to durable cure?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "NO",
          "description": "A clinical trial suggest that inhibition of this target does not improve TB chemotherapy in humans.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "1be7862e-e4b0-4cea-ac69-e31edbd942a7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "YES",
          "description": "An approved drug that engages this target and has shown to be part of a sterilizing regimen.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 49.5,
          "id": "fb941679-d919-495e-a3c8-5b4b48567103",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "UNKNOWN",
          "description": "No drug or candidate that engages the target has progressed to a level of clinical evaluation that could demonstrate a contribution to a durable cure.  Alternatively, a clinical trial was inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.5,
          "id": "3370b2b4-5a8c-401d-a99f-fe651812fed2",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "423ee452-bc62-4aad-a97b-546bc91e4afe",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2A1B",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Humans-Active in EBA?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "UNKNOWN",
          "description": "No drug that engages the target has progressed to a Phase 2 EBA study.  Alternatively, the level of target engagement for a particular drug that has progressed to an EBA study is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "4a6fbf12-ed3c-4450-9d32-1c04d0a46e7e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "YES",
          "description": "A drug that engages the target was shown to be active in an EBA study as determined by the clinical team.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "eb7d1448-c5e5-4eb7-95cd-559afe135d23",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "NO",
          "description": "A drug that engages the target was shown to be inactive in an EBA study as determined by the clinical team.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "ab0f63c5-18da-45dc-ac76-c1fab3660e5f",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "NHP (Active/Inactive/Unknown)?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a NHP study as determined by the study team.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 14.85,
          "id": "910e3f90-f97c-416b-968f-5f7522a8c4c4",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a NHP study as determined by the study team.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "1306ab66-0a58-471d-b5f0-ce8c66050fe9",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a non-human primate efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a NHP study is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.15,
          "id": "e2e4edd6-b1e4-47ec-ad4e-45024a4c98bb",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2A4A",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "C57BL/6 or BALB/c-Acute infection?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a C57BL/6 or BALB/c-Acute infection efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a C57BL/6 or BALB/c-Acute infection efficacy study is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.11,
          "id": "185eb3d4-a248-49f9-b8b0-9e594aa6184c",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a C57BL/6 or BALB/c-Acute infection efficacy study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 10.89,
          "id": "db70a496-ce06-4f9e-9101-af42643ddce7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a C57BL/6 or BALB/c-Acute infection efficacy study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "1a81d93c-9e3d-42dc-80c4-26551505c592",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "0402e931-370a-4ca4-bfb7-f53c0868801a",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2A4B",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "C57BL/6 or BALB/c-Chronic infection?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a C57BL/6 or BALB/c-Chronic infection efficacy study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "ba93424e-9173-42d0-b755-6ec14e3d2b40",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a C57BL/6 or BALB/c-Chronic infection efficacy study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 10.89,
          "id": "9975cd3a-4a48-429f-b6bb-ba43bdba48d4",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a C57BL/6 or BALB/c-Chronic infection efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a C57BL/6 or BALB/c-Chronic infection efficacy study is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.11,
          "id": "2853e86b-94cf-418c-b39f-fa40e200532a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2A5",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Macrophage?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in a macrophage assay.  Alternatively, the level of target engagement for a particular compound that has been tested in a macrophage assay is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.02,
          "id": "fc6c7f55-b532-412d-ad3c-660804f2d912",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a macrophage assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "e3735f46-1411-4c5e-aaf1-56dea2399a26",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a macrophage assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1.98,
          "id": "f437a533-d6d0-46da-bf02-7b6f4f60fc94",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "f397ac6f-1545-4986-b23e-d9bb968482e0",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Standard media?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay using standard media.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 49.5,
          "id": "90630c16-7d59-4748-be50-62933f9834ab",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay using standard media.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "0c4f1efd-26e1-4ee9-b676-8fa27bf3b56c",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay using standard media.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay using standard media is uncertain.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.5,
          "id": "555796e3-cb6d-49b5-bfc5-4148bad1d168",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Gluconeogenic carbon source?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay using a gluconeogenic carbon source.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 24.75,
          "id": "d04a4017-b772-4b43-bb26-6dc3cf2d7723",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay using a gluconeogenic carbon source.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay using a gluconeogenic carbon source is uncertain. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.25,
          "id": "d6dd9139-e941-4374-9f39-08581834a624",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay using a gluconeogenic carbon source. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "201e6768-7e15-4ee0-a72b-8fe2e9869a64",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "15359627-6fb8-440d-b29e-197637294eae",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2B4",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Other?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay under other conditions. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "4a1856bf-3532-4802-a311-0c4890910d92",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay under other conditions.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 24.75,
          "id": "d5c9a1cd-c15a-4a1f-8ef0-8b736dacf442",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay under other conditions.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay under other conditions is uncertain.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.25,
          "id": "2ae72e7f-6826-4bcd-a99c-286b5adbb7a0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Caseum or caseum surrogate?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay in caseum or caseum surrogate.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay in caseum is uncertain.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.9,
          "id": "64339af1-c124-4a1b-9a05-68b7ccdc4fbf",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay in caseum or caseum surrogate. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 89.1,
          "id": "9a677515-1393-4c3f-b256-f6fa1c3c35b8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay in caseum or caseum surrogate. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "3cefb3fe-1136-4ca9-b4ef-c09b8ad30027",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "49488323-7b56-4562-aa09-7fc1e607d815",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "2C5",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Other NR?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay under other NR conditions.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay under other NR conditions is uncertain.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.1,
          "id": "d65c28dc-7711-4058-83b4-fb9180e5e149",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay under other NR conditions.  Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 9.9,
          "id": "274c7bb9-00e9-4977-ba07-115487d945ab",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay under other NR conditions. Please describe conditions.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "092842fa-1420-4182-8b76-435dee5877d8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Mutation in target causes resistance?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria with mutations in the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "ed38fc6a-94fc-4351-9431-61ef6a72d9a2",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria with mutations in the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "04917cf2-a57c-4346-97b7-52d3760a61a0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "UNKNOWN",
          "description": "Mutation studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, mutation studies on compounds that are thought to engage the target are inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "4ad7aefd-8a8a-469e-a295-eb90bcac315e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Overexpression of target increases MIC?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "UNKNOWN",
          "description": "Testing compounds on bacteria that over express the target has not been undertaken.  Alternatively, overexpression studies on compounds that are thought to engage the target are inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "104432d2-d9e2-43af-9f6e-d712f76d4892",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria that overexpress the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "60383858-ad0b-4dce-9b82-704c97b55dba",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria that overexpress the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "17a4e1ac-5e68-4282-8311-a6c957c80d6e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "0014c1e6-0741-470a-8043-810ae0e9928c",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Underexpression of target decreases MIC?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "UNKNOWN",
          "description": "Testing compounds on bacteria that under express the target has not been undertaken.  Alternatively, underexpression studies on compounds that are thought to engage the target are inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "c55a740e-3889-4f04-9d1c-23fd479bd4ff",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria that underexpress the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "ba10577a-00a9-40a7-8f5c-8bf35ab84c40",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria that underexpress the target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "df414f57-fd33-4688-9ab9-315b191c42e7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Impact on pathway?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "YES",
          "description": "Compounds have an impact on the pathway that the target of interest is part of. Please describe studies that were undertaken.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "defc7477-4085-4c24-9d81-de7fa637e1d8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "UNKNOWN",
          "description": "Pathway studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, pathway studies on compounds that are thought to engage the target are inconclusive.  Please describe studies that were undertaken.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "d72e8a99-c36d-4ed2-bf1c-a2c596e823d8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "NO",
          "description": "Compounds do not have an impact on the pathway that the target of interest is part of. Please describe studies that were undertaken.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "78693ade-9480-4dd5-b69b-d67ace54efa7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(b) Biochemical activity (isolated target)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Compound binds purified target?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "NO",
          "description": "Compounds do not bind purified target.  Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "2ebbd133-49f3-4ca1-b097-6ccd198e61d7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "UNKNOWN",
          "description": "Binding studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, binding studies on compounds that are thought to engage the target are inconclusive.  Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "0cd490b6-99b9-47b2-a558-0d80dacddeae",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "YES",
          "description": "Compounds bind purified target. Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "7ef14939-90a9-42cf-98bb-f40c7b78d41e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "f3e66764-087f-471b-ad56-61c8ba28a386",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "3B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(b) Biochemical activity (isolated target)",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Compound inhibits purified target?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "YES",
          "description": "Compounds inhibit purified target. Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 16.5,
          "id": "1a999236-19b5-4757-a0a5-79b4ae09912b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "NO",
          "description": "Compounds do not inhibit purified target. Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "d635b67d-4e0f-4c77-8c1f-7fc5817d83b6",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "UNKNOWN",
          "description": "Inhibition studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, inhibition studies on compounds that are thought to engage the target are inconclusive. Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.2,
          "id": "958b7b76-1e99-453e-99df-fad707a4d960",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "925b0c93-cb75-4770-a0d7-3ef06985934d",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "4A3A",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "C57BL/6 or BALB/c-Acute infection?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a C57BL/6 or BALB/c-Acute efficacy study.  Alternatively, the outcome from genetically modified bacteria in an acute C57BL/6 or BALB/c mouse study was inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.5,
          "id": "0960be4f-f219-4abb-9fed-9c581a1636a4",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the course of the infection in a C57BL/6 or BALB/c-Acute study with genetically modified bacteria.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 49.5,
          "id": "d3a1b586-3ac4-4b71-a36b-6576af6df90d",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "INACTIVE",
          "description": "There was no significant impact on the course of the infection in a C57BL/6 or BALB/c-Acute study with genetically modified bacteria.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "4be8c3b0-2e90-4d46-80fb-b5574b766b7b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "4A3B",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "C57BL/6 or BALB/c-Chronic infection?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the course of the infection in a C57BL/6 or BALB/c-Chronic study with genetically modified bacteria.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 49.5,
          "id": "ea6df497-78ad-4da6-8096-7e07fbca2232",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "INACTIVE",
          "description": "There was no significant impact on the course of the infection in a C57BL/6 or BALB/c-Chronic study with genetically modified bacteria.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "f0c4fe68-56ae-4dc3-9399-4260ec68f72f",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a C57BL/6 or BALB/c-Chronic efficacy study.  Alternatively, the outcome from genetically modified bacteria in a chronic C57BL/6 or BALB/c mouse study was inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.5,
          "id": "aee385f0-47e5-4d81-8425-aff02884e09c",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "42eb9699-e066-474d-bc64-9fed34f453a3",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "4A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Macrophage?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a macrophage study.  Alternatively, the outcome from a macrophage study using genetically modified bacteria was inconclusive.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "3701124f-7ca0-4a8e-9275-531016cbe3f0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "ACTIVE",
          "description": "Genetic inactivation of the target significantly reduced growth of Mtb (p-value < 0.05) in naÃ¯ve macrophages and/or increased killing by activated macrophages (p-value < 0.05).",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "9b0d0572-a176-4b11-8460-6134e7d24e43",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "INACTIVE",
          "description": "Genetic inactivation of the target did not significantly change growth in or killing by macrophages.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "92fc940f-49e5-4b4e-90ea-b92032c3acd0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "4C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Caseum surrogate?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "INACTIVE",
          "description": "There was not a significant impact on the relative growth behavior of genetically modified bacteria tested in caseum surrogate.  Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "bc2ed45c-12fd-4305-9061-e977b578db57",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been prepared and/or were not tested in caseum surrogate.  Alternatively, the outcome from a genetically modified bacteria growth study in caseum surrogate was inconclusive.  Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.9,
          "id": "3fe00e55-ef75-4b26-8492-f2e8664f85ad",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the relative growth behavior of genetically modified bacteria tested in caseum surrogate.  Please describe assay.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 89.1,
          "id": "5b5c73bd-7a65-4d39-a68c-cc785252c8f1",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "5A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "a) Metabolic liabilities",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Target inhibition/activation can be neutralized by a supplement (eg a metabolite) or in specific media?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "YES",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media exists and has been demonstrated in vitro or in vivo. Please describe situation.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "3106b75d-13c4-4695-a84d-b08de86a11ee",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "N/A",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media does not exist.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "8b84b337-9839-4e29-9126-0f2ff7148c53",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "UNKNOWN",
          "description": "The possibility of inhibition or inactivation neutralization of inhibition or inactivation by a supplement or specific media exists but has not been demonstrated in vitro or in vivo. Please describe situation.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "ad64cd1e-9b04-4b71-8c3c-6ebc227e754d",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "NO",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media is theoretically possible but has been excluded experimentally.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "213c353e-f7df-40f8-b8e6-f3b84daa9dce",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "5A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "a) Metabolic liabilities",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Concentration of supplement in human tissue is too low to neutralize inactivation?",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "YES",
          "description": "If it is known that the concentration of supplement in human tissue is too low to neutralize inactivation of the target, please elaborate.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "285abefa-1ad9-4943-8317-0840f7f09d69",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "NO",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media does not exist.  Alternatively, the possibility of inhibition or inactivation neutralization by a supplement or specific media exists but concentrations in human tissue are insufficient to accomplish this. Please describe situation.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0,
          "id": "112bfdf6-2126-4981-a1b7-50e7e395140a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "UNKNOWN",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media exists but it is unknown, or it has not been demonstrated that concentrations in human tissue are sufficient to accomplish this. Please describe situation.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.75,
          "id": "088b898f-0a73-4be6-981c-88d1f3bd0ba5",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "4e918e13-3418-4b85-923e-0ab347df3fef",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "5A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "b) Genetic",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Does the Mtb genome contain multiple paralogs?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "NO",
          "description": "The Mtb genome does not contain functionally redundant genes.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "c092ce4d-28f1-4bb5-ad8d-8669f2751258",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "7b57e573-eb6f-49c3-acbf-6b5092eb0814",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "YES",
          "description": "The Mtb genome contains functionally redundant genes.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.7,
          "id": "18da1ce2-b4ad-4337-995e-409c7ac86744",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "02f742df-3af2-4930-b1d9-2e811e070afa",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "5B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "c) Other",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Have Inhibitors with low cellular toxicity been identified, or does the protein contain an active or allosteric site that is different from the human counterpart?",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "9d72eb0d-a36b-4e94-a0ed-5d6b86c7e50b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "YES",
          "description": "Inhibitors with low cellular toxicity have been identified.  Alternatively, the protein does contain an active or allosteric site that is different than the human ortholog.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 1,
          "id": "aa5a236f-4d7f-4e53-bf8c-47b0293f3dcc",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "NO",
          "description": "The protein has an active or allosteric site that is similar to the human ortholog.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": 0.5,
          "id": "d546d8c5-4bde-44ec-9e12-82bf469dcb39",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Protein has been expressed and can be prepared",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question or protein preparation on has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b6667118-1e97-4320-8220-e631cc1d08e6",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "NO",
          "description": "Attempts to prepare the protein have been unsuccessful.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "1a8b6ecf-9185-4739-93a7-50a08ab1d5d8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "YES",
          "description": "The protein can be prepared.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "5f31672b-6698-4203-a4b5-f49e1d1a4529",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Assays for Mtb protein have been established",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "YES",
          "description": "An assay for Mtb protein has been established.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b4334e9e-5e27-4963-9f6e-d1383866c648",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, an assay for this protein has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0700fa3b-c7ee-4c0b-906b-5bbe5f39cf1f",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "NO",
          "description": "An assay for Mtb protein has been attempted but has not been established.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "f5a76724-b50a-4be6-b82c-88c2da82a21a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Assay has been established for an ortholog from another species",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, an assay for this protein has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "47a207d1-462a-46e1-8567-15119e5a2dae",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "NO",
          "description": "An assay for an ortholog has been attempted but has not been established.  Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "d70204f5-be44-4c49-a60a-21345dda0dba",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "YES",
          "description": "An assay for an ortholog has been established.  Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0fbbc55e-39ac-4e3f-97be-1d5a8e29ba14",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "High throughput screening is possible",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "NO",
          "description": "Factors make HTS screening of this protein difficult or impossible (i.e., there is one or more \"no\" responses to the following sub questions). Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "cac63c85-89f6-478b-a17f-1a8895d40b2b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, a HTS screen for this protein has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0ac53722-5b14-4181-8a27-8a2373c59e39",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "YES",
          "description": "An HTS screen has been performed.  Alternatively, answers to sub-questions indicate that screening is feasible. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "d67885c0-83a1-4f53-acd6-47b3147d770b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A4A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Protein available in sufficient quantity for HTS",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0788172a-c1f3-409a-b858-cb0c27f3d982",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "YES",
          "description": "Methods to prepare sufficient quantity of protein are available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "44baad41-4342-4084-8091-15ecd453fed2",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "NO",
          "description": "Methods to prepare sufficient quantity of protein are not available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0346d89f-b72a-40dd-b344-e40efdb04d51",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "e0c572fc-9d15-4690-ad62-2760013761b7",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A4B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Is assay type a member of a list of appropriate assay methods for HTS",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "YES",
          "description": "Assay type is a member of the following list.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "175714fa-a4b3-410e-b1e6-c5359fccd4bb",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b1ecdb4c-dc96-45cb-8e13-bc266f47a59d",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "NO",
          "description": "Assay type is not a member of the following list.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0b012f5f-04cf-4468-8f66-062f51874069",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A4C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "No logistical impediments to screening",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "67200b85-4a13-4559-8046-8a4d7f8de87c",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "YES",
          "description": "There are no impediments.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "93d10d19-e13d-455b-ad9f-b32bcc83756e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "NO",
          "description": "There are impediments.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "7c0e7a9c-d840-4b9b-afb0-2207383c9556",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "0d493be4-7dd9-40bd-b683-929729fca7be",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A5",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Small scale screening is possible",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "NO",
          "description": "Attempts to setup small-scale screens were unsuccessful.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "8d6d7cff-50c7-4a9b-8fa9-60d25ed9118b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "YES",
          "description": "A small scale screen has been performed.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "3018a818-44bb-4359-9481-45ce5b5a05e5",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, a small-scale screen for this protein has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "81735a9d-c6d8-4470-a25c-0710a624bd81",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "7d864773-d8d9-4962-8763-ccdea030e6b7",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A6",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Large-scale screens for the Mtb have been performed",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "YES",
          "description": "A large-scale16 screen has been performed. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "f6f2014b-6650-448e-a4d1-7eacaa48b204",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "NO",
          "description": "Attempts to run a large-scale16 screen were unsuccessful. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "6b180d3c-133b-4b79-b3b2-3a9506677697",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question. Alternatively, a large-scale screen for this protein has not been attempted.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "8d84d49e-406a-4abd-8693-4894b15ff3f5",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A6A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Have multiple unsuccessful large-scale screens been run against this target?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "YES",
          "description": "There have been multiple unsuccessful large-scale screens run against this target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "372aaff7-2c51-4575-bbf7-f71b66f36941",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "NO",
          "description": "There have not been multiple unsuccessful large-scale screens run against this target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9b3c3e4b-5405-4793-80af-9534681683ad",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "UNKNOWN",
          "description": "It is not known whether multiple unsuccessful large-scale screens have been run against this target.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "2b0e191a-4910-4020-b262-0b9fc6e4bce0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6A7",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Compounds have been identified that bind purified target?",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "UNKNOWN",
          "description": "Binding studies have not been undertaken on compounds that are thought to engage1 the target.  Alternatively, binding studies on compounds that are thought to engage1 the target are inconclusive.  Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "2de8fc3b-743d-4757-a767-8096e5dd0206",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "YES",
          "description": "Compounds bind purified target. Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "0f287415-56b7-4539-a06a-019eb37d263e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "NO",
          "description": "Compounds do not bind purified target. Please describe type of study.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "40882978-8e77-4dd7-a36c-0fdf6938741d",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Relevance of Mtb protein structure",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "43607bbf-5119-451a-9803-3f384882d150",
          "answer": "MEDIUM",
          "description": "Answer to question 6b1a is \"Yes\", 6b1b is \"Medium\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "765a1ac6-6beb-4220-9b19-286e97c4b492",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "43607bbf-5119-451a-9803-3f384882d150",
          "answer": "HIGH",
          "description": "Answer to 6b1d and/or 6b1e is \"Yes\".  Alternatively, answer to question 6b1a is \"Yes\", 6b1b is \"High\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "be34f1ec-6b33-4d1d-83e5-e1745ce5810b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "43607bbf-5119-451a-9803-3f384882d150",
          "answer": "N/A",
          "description": "Answer to question 6b1a is \"No\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "6291a89e-77bc-4db8-819f-1ba8403f95d4",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "43607bbf-5119-451a-9803-3f384882d150",
          "answer": "LOW",
          "description": "Answer to question 6b1a is \"Yes\", 6b1b is \"Low\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "53dd8552-c822-400b-8161-c08bd49babe5",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "43607bbf-5119-451a-9803-3f384882d150",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B1C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Are you aware of any unpublished Mtb structural data for this target?",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3cb8fa23-f4e8-4eb4-967a-f25ce8cceb3c",
          "answer": "NO",
          "description": "The submitter is unaware of any unpublished data.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "6ba32b07-13d9-4ab5-b283-3ecd04fdddc3",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "3cb8fa23-f4e8-4eb4-967a-f25ce8cceb3c",
          "answer": "YES",
          "description": "An unpublished structure is available and provided for analysis. Please attach.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "add0fc45-3828-4a9b-9f98-3b81d18c1c26",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "3cb8fa23-f4e8-4eb4-967a-f25ce8cceb3c",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B1D",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Has there been successful structure-based design efforts performed on this target?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "NO",
          "description": "Attempts to perform structure-based design were unsuccessful. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "612b5137-6935-4a41-a3e4-161a8ff33c01",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "YES",
          "description": "A successful structure-based design effort has been performed. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "35993d99-30a2-481f-8ca8-0e4d09fba898",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "2a196b80-687b-4587-8c64-c26953e82aaf",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B1E",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Has there been successful virtual screening efforts performed on this target?",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "YES",
          "description": "A successful virtual screening effort has been performed. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "5ec26d70-dbef-4e0f-be01-c8682bad0a3b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "6cce8f65-28a2-4037-9d1d-3416cb62bd5f",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "NO",
          "description": "Attempts to perform virtual screening were unsuccessful. Please provide details.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9bd3361a-66b4-4deb-af91-ce3b0e312143",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Mtb protein structure(s) quality",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "949376fd-4dad-42ea-bf7f-a7ac53311715",
          "answer": "HIGH",
          "description": "Answer to question 6b2a is \"Yes\", or answer to questions 6b2b and 6b2c are \"Yes\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "f4fbb5b1-2eea-4fad-9e4a-b7b5fa8ce7d9",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "949376fd-4dad-42ea-bf7f-a7ac53311715",
          "answer": "LOW",
          "description": "Answer to questions 6b2a, 6b2b and 6b2c are \"No\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "1f84a805-a2dc-4f19-a8e7-5ee04ca1a351",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "949376fd-4dad-42ea-bf7f-a7ac53311715",
          "answer": "MEDIUM",
          "description": "Answer to questions 6b2a is \"No\" and 6b2b is \"Yes\" and 6b2c is \"No\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "08552a45-d5c4-4aae-b755-a54b75428c69",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "949376fd-4dad-42ea-bf7f-a7ac53311715",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B3",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Relevance of ortholog protein structure.",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "7c8f5a34-94f2-4969-a1bc-e42caad24669",
          "answer": "MEDIUM",
          "description": "Answer to question 6b3a is \"Yes\", 6b3b is \"Medium\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "071a4a12-0c19-4745-9b8d-bc7b0ef114a7",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "7c8f5a34-94f2-4969-a1bc-e42caad24669",
          "answer": "HIGH",
          "description": "Answer to question 6b3a is \"Yes\", 6b3b is \"High\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "34c8080e-821e-466d-ac3f-53910a163897",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "7c8f5a34-94f2-4969-a1bc-e42caad24669",
          "answer": "LOW",
          "description": "Answer to question 6b3a is \"Yes\", 6b3b is \"Low\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "a37c5f6a-24e4-4cfc-8306-467870ef1e2a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "7c8f5a34-94f2-4969-a1bc-e42caad24669",
          "answer": "N/A",
          "description": "Answer to question 6b3a is \"No\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "1e74049d-28bf-49f6-bb1e-0445729cbf60",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "7c8f5a34-94f2-4969-a1bc-e42caad24669",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B3D",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Are you aware of any unpublished ortholog structural data for this target?",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
          "answer": "YES",
          "description": "An unpublished structure is available and provided for analysis. Please attach.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "c9759129-3010-415e-af05-874546cbb879",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
          "answer": "NO",
          "description": "A structure is not available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9bc8e45e-2d0d-41fd-88b0-15aa5a7e7b5a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Ortholog structure(s) quality",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "69e6aa4a-383b-4345-8928-84b7ae9e8019",
          "answer": "MEDIUM",
          "description": "Answer to questions 6b4a is \"No\" and 6b4b is \"Yes\" and 6b4c is \"No\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9e22c620-b3bd-492d-938f-7da840c22286",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "69e6aa4a-383b-4345-8928-84b7ae9e8019",
          "answer": "HIGH",
          "description": "Answer to question 6b4a is \"Yes\", or answer to questions 6b4b and 6b4c are \"Yes\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "7b1b84fd-b638-42bb-a09e-3e6e3212fa29",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "69e6aa4a-383b-4345-8928-84b7ae9e8019",
          "answer": "LOW",
          "description": "Answer to questions 6b4a, 6b4b and 6b4c are \"No\"",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "70cc7141-05e3-4b9d-9cca-aa6819d86d9c",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "69e6aa4a-383b-4345-8928-84b7ae9e8019",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6B5",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Overall druggability of the protein pocket or binding epitope",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "HIGH",
          "description": "Answer to question 6b1 is \"High\".  Alternatively, if answer to 6b3 is not \"Low\" and answer to 6b5a is \"High\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "5ca84d27-722b-4e8f-bd39-b66fd9a4fa42",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "LOW",
          "description": "If answer to 6b3 is \"Low\".  Alternatively, if answer to 6b3 is not low and answer to 6b5a is \"Low\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "3fa54dab-f504-4b16-98fe-750b6bbe4e99",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "MEDIUM",
          "description": "If answer to 6b3 is not \"Low\" and answer to 6b5a is \"Medium\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "ef7b5f19-d103-4e26-b9be-f6092521da36",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "N/A",
          "description": "Answer to question 6b1a is \"No\".",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "d78f7649-4041-40d9-8904-7088b1a2436b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Mtb strains that can confirm on target activity are available",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "72e48f78-d3e8-4292-96b6-f934b00a6f45",
          "answer": "YES",
          "description": "There are Mtb strains available that can confirm on target activity.  These include overexpressors, knockdowns and/or knockouts.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "d9c56c84-c889-423b-a052-977583196a40",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "72e48f78-d3e8-4292-96b6-f934b00a6f45",
          "answer": "NO",
          "description": "There strains are not available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "a7196850-4485-4787-b709-1a2f25d0ac71",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "72e48f78-d3e8-4292-96b6-f934b00a6f45",
          "answer": "UNKNOWN",
          "description": "It is unknown whether strains are available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "073a282f-aa80-45dc-bd05-597a8ce1d362",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "72e48f78-d3e8-4292-96b6-f934b00a6f45",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Compounds have been identified that have on-target whole cell activity",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c328deed-1e2f-432e-b8ca-6e195d30db32",
          "answer": "NO",
          "description": "Compounds have not been identified that have on-target whole cell activity.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "54b1bd79-a872-42bf-8504-445af47ca763",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "c328deed-1e2f-432e-b8ca-6e195d30db32",
          "answer": "YES",
          "description": "Compounds have been identified that have on-target whole cell activity.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b01920ba-2680-48fb-9153-04758a166f10",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "c328deed-1e2f-432e-b8ca-6e195d30db32",
          "answer": "UNKNOWN",
          "description": "It is unknown whether compounds have been identified that have on-target whole cell activity.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9f87e966-6744-4c60-9a64-1c33daf94454",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "c328deed-1e2f-432e-b8ca-6e195d30db32",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Inhibitors of orthologs in Mtb and/or other species identified",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "48fe0628-f6ed-4d93-8a56-1808296d0300",
          "answer": "UNKNOWN",
          "description": "It is unknown whether Inhibitors of orthologs in Mtb and/or other species have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "5c4e5d95-6cf5-4abb-8ece-6316abf19a27",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "48fe0628-f6ed-4d93-8a56-1808296d0300",
          "answer": "YES",
          "description": "Inhibitors of orthologs in Mtb and/or other species have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "87b77cab-87fe-40e5-a33a-43f495bbaac0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "48fe0628-f6ed-4d93-8a56-1808296d0300",
          "answer": "NO",
          "description": "Inhibitors of orthologs in Mtb and/or other species have been not identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "67d25ddf-86e7-44e3-97c5-b206f3efd82a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "48fe0628-f6ed-4d93-8a56-1808296d0300",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Drugs targeting orthologs in Mtb and/or other species are known",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "432e51c6-3559-4288-9667-3e0ecb51e867",
          "answer": "NO",
          "description": "Drugs targeting orthologs in Mtb and/or other species are not known.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "91f0134c-b272-4cdf-baf3-ea6f9fda564e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "432e51c6-3559-4288-9667-3e0ecb51e867",
          "answer": "YES",
          "description": "Drugs targeting orthologs in Mtb and/or other species are known.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "cf28b977-f7bc-4a17-8895-a92bb443dd6d",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "432e51c6-3559-4288-9667-3e0ecb51e867",
          "answer": "UNKNOWN",
          "description": "It is unknown whether drugs targeting orthologs in Mtb and/or other species known.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "e397212b-0b13-495c-bffd-6a3ae386075e",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "432e51c6-3559-4288-9667-3e0ecb51e867",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C5A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Inhibitors of orthologs in Mtb and/or other species are known",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "b4066987-2649-4dc1-a32e-c8c36387d55f",
          "answer": "YES",
          "description": "Inhibitors targeting orthologs in Mtb and/or other species are known.  Please provide reference or structure.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "4a03a9fa-9330-4dbd-bbd9-b16b41b730b5",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "b4066987-2649-4dc1-a32e-c8c36387d55f",
          "answer": "NO",
          "description": "Inhibitors targeting orthologs in Mtb and/or other species are not known.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "f671f070-565a-4cd5-86e9-1bfe0cf5c5e8",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "b4066987-2649-4dc1-a32e-c8c36387d55f",
          "answer": "UNKNOWN",
          "description": "It is unknown whether Inhibitors targeting orthologs in Mtb and/or other species are known.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "d25fa508-245e-437b-86f5-07015bf422ac",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "b4066987-2649-4dc1-a32e-c8c36387d55f",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6C6",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "Progress of compounds with confirmed on-target activity. Choose all you are aware of.",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "LO",
          "description": "A compound with on-target whole cell activity is in H2L within the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "883a18ad-617d-47d7-84a1-3e7b3ce8cbc6",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "H2L",
          "description": "A compound with on-target whole cell activity is under hit evaluation within the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b58eeb03-e0b1-4ffe-8d81-e5f63beee66b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "HA",
          "description": "A compound with on-target whole cell activity is under hit evaluation within the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "db8d2961-62b0-4b97-b1db-3bacbb05113b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "SP",
          "description": "A compound with on-target whole cell activity is in SP within the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "437cb6d6-ae36-4939-bb75-5d0ea1ca0ba2",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "PCD",
          "description": "A compound with on-target whole cell activity has been nominated as a PCD candidate in the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "50a6fe29-1534-4463-b3b5-e1ae7f940cd9",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "SCREENING HIT",
          "description": "A compound with on-target whole cell activity has been identified as a screening hit within the TBDA.  Alternatively, a publication or personal knowledge of a compound outside the TBDA supports this stage assessment.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "a11f93c7-f827-4da4-bc67-067cb492a1ca",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "CLINIC",
          "description": "A compound with on-target whole cell activity is under clinical investigation.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "a93bb085-31fb-4caf-8961-30ff70e4f279",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "DRUG",
          "description": "A compound with on-target whole cell activity is an approved drug.  Please provide reference.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "3f29d15b-1989-4751-a705-55c4f29aa948",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6D2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "The consequence of inhibiting the human ortholog is significant",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "NO",
          "description": "The consequence of inhibiting the human ortholog is not significant.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "72e6d146-826e-4ab4-b5b5-f63dac6e2ea0",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "UNKNOWN",
          "description": "It is unknown what the consequence of inhibiting the human ortholog is.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "df8ab74b-0ac3-4fb3-a344-49dce6697db3",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "YES",
          "description": "The consequence of inhibiting the human ortholog is significant.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "042b689f-8f62-4254-9c02-8f2f9dec4ee6",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "f520aa0f-3b03-4397-91d3-a22554b9da91",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6D4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "sectionDescription": null,
      "subSectionDescription": null,
      "questionBody": "non-Mtb strains which could be used to characterize compounds with broad spectrum activity are available",
      "notes": null,
      "toolTip": null,
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "NO",
          "description": "Mtb strains which could be used to characterize compounds with broad spectrum activity are not available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "b3eb6500-a683-45a6-bfeb-e7484d6a7ead",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "UNKNOWN",
          "description": "It is unknown whether Mtb strains which could be used to characterize compounds with broad spectrum activity are available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "1bd1459e-22e5-408e-8937-6c40e5432b37",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "YES",
          "description": "Mtb strains which could be used to characterize compounds with broad spectrum activity are available.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "9ebe4757-bdbb-431a-ae0d-56a857c88881",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    },
    {
      "identification": "6D5",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "sectionDescription": "",
      "subSectionDescription": null,
      "questionBody": "Safety assessment of compounds with confirmed on-target activity",
      "notes": null,
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isMultiple": null,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "DRUG WO WARNINGS",
          "description": "A marketed drug without serious safety related warnings, precautions, adverse events, or restrictions on dose/populations.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "8eeee508-321f-46b2-b4f4-4bd2e0f7d81a",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "ACUTE EFFICACY",
          "description": "Inhibitors which showed no toxicity in acute efficacy studies have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "8317dcc2-ada2-46f7-a6eb-c8c74dd8bd7b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "PRECLINICAL SAFETY",
          "description": "Inhibitors which showed no toxicity in in vivo preclinical safety studies have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "00a5892f-f0c4-47aa-bd35-27174c42de6b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "IND ENABLING",
          "description": "Drug candidates which showed no toxicity in IND enabling safety studies have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "2882dbd6-f90b-4983-976c-a3e6cacfea06",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "NON-CYTOTOXIC",
          "description": "Inhibitors which are not generally cytotoxic have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "80632cc9-397d-4d42-8209-59e38121e079",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "DRUG W/WARNINGS",
          "description": "A marketed drug with serious safety related warnings, precautions, adverse events, or restrictions on dose/populations.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "395f32b5-e991-4ad0-a4f0-5e58a9d2d1ce",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "CHRONIC EFFICACY",
          "description": "Inhibitors which showed no toxicity in chronic efficacy studies have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "6581d0cc-ef8d-41c0-bcf1-1ec1b920374b",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        },
        {
          "questionId": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
          "answer": "CLINICAL",
          "description": "Drugs which showed no toxicity in clinical studies have been identified.",
          "color": null,
          "icon": null,
          "isInverted": null,
          "weight": null,
          "id": "a281b19e-b4c1-4820-b2ac-88a3a5060d25",
          "isArchived": false,
          "isDeleted": false,
          "publications": []
        }
      ],
      "id": "dde1b063-65e5-42f0-8b2c-45c6939d3113",
      "isArchived": false,
      "isDeleted": false,
      "publications": []
    }
  ],
  "id": "adeb1032-fa87-4c5f-9a1d-be4a83bfcdeb",
  "isArchived": false,
  "isDeleted": false,
  "lastModifiedById": "6206af6d-124a-46d4-a261-b3d529e443be",
  "dateModified": "2025-05-27T18:36:59.468Z",
  "isModified": true,
  "publications": []
}
